scispace - formally typeset
Y

Yi-Lin Chan

Researcher at Chinese Culture University

Publications -  43
Citations -  1657

Yi-Lin Chan is an academic researcher from Chinese Culture University. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 23, co-authored 42 publications receiving 1359 citations. Previous affiliations of Yi-Lin Chan include National Defense Medical Center & Academia Sinica.

Papers
More filters
Journal ArticleDOI

Inhibition of Lipopolysaccharide (LPS)-Induced Inflammatory Responses by Sargassum hemiphyllum Sulfated Polysaccharide Extract in RAW 264.7 Macrophage Cells

TL;DR: The secretion profiles of pro-inflammatory cytokines were found significantly to be reduced in 1-5 mg/mL dose ranges of SHSP treatments, and RT-PCR analysis suggested SHSP inhibits the LPS-induced mRNA expressions of IL-β, iNOS, and COX-2 in a dose-dependent manner.
Journal ArticleDOI

Inhibition of SARS-CoV replication by siRNA.

TL;DR: It is demonstrated that siRNAs directed against Spike sequences and the 3′-UTR can inhibit the replication of SARS-CoV in Vero-E6 cells, and holds out promise for the development of an effective antiviral agent against SARS -CoV.
Journal ArticleDOI

The Cellular Antiviral Protein Viperin Is Attenuated by Proteasome-Mediated Protein Degradation in Japanese Encephalitis Virus-Infected Cells

TL;DR: Viperin gene expression is highly induced at the RNA level by Japanese encephalitis virus and Sindbis virus and that viperin protein is degraded in JEV-infected cells through a proteasome-dependent mechanism, suggesting it is negatively regulated at the protein level to counteract its antiviral effect.
Journal Article

Tumor-associated antigen L6 and the invasion of human lung cancer cells

TL;DR: TAL6 appears to be involved in cancer invasion and metastasis, and real-time reverse transcription-PCR of lung cancer specimens showed that increased expression of TAL6 was significantly associated with early postoperative relapse and shorter survival in squamous cell lung cancer patients.
Journal ArticleDOI

Prophylactic Administration of Fucoidan Represses Cancer Metastasis by Inhibiting Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinases (MMPs) in Lewis Tumor-Bearing Mice

TL;DR: It is discovered that administration of fucoidan has prophylactic effects on mitigation of cachectic body weight loss and improvement of lung masses in tumor-inoculated mice, and is suitable to act as a chemo-preventative agent for minimizing cachectic symptoms and inhibiting lung carcinoma metastasis through down-regulating metastatic factors VEGF and MMPs.